CME webinar: Hepatitis C, B, and HIV: Screening and Management

Mar. 2024Education/Webinars
Please join us for a live, continuing medical education (CME)-accredited webinar on Wednesday, May 1, from noon to 1 p.m. The webinar will provide an overview of hepatitis C, B, and HIV screening and management. During this presentation, our expert will:
  • Review the prevalence, trends, and screening recommendations for hepatitis B, C, and HIV.
  • Discuss recommended screening tests and the interpretation of the results.
  • Review the management of hepatitis C and the role of primary care in its treatment.
  • Discuss considerations with hepatitis C, B, and HIV coinfections.

Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan

Register now.

This webinar will be recorded.

This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.

Provider is responsible for verifying CME eligibility.

Recent Announcements

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates

Voluntary nationwide recall: Dextrose (Baxter – August 2026)

Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.
Sep. 2026Pharmacy Updates